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Diego Sangiorgi, MSTAT,* Laura Alessi, MD,* Stefano De Servi, MD,‡ Angelo Branzi, MD,*
Gregg W. Stone, MD§
Bologna, Rome, and Legnano, Italy; and New York, New York
Objectives This study sought to determine whether coronary artery bypass graft (CABG) surgery is associated with an in-
creased risk of stroke compared with percutaneous coronary intervention (PCI).
Background Some, but not all, randomized trials have reported increased rates of stroke with CABG compared with PCI. How-
ever, all these studies were powered insufficiently to examine differences in the risk of stroke reliably.
Methods We performed a meta-analysis of 19 trials in which 10,944 patients were randomized to CABG versus PCI. The
primary end point was the 30-day rate of stroke. We also determined the rate of stroke at the midterm follow-up
and investigated whether there was an interaction between revascularization type and the extent of coronary
artery disease on the relative risk of stroke.
Results The 30-day rate of stroke was 1.20% after CABG compared with 0.34% after PCI (odds ratio: 2.94, 95% confi-
dence interval: 1.69 to 5.09, p  0.0001). Similar results were observed after a median follow-up of 12.1
months (1.83% vs. 0.99%, odds ratio: 1.67, 95% confidence interval: 1.09 to 2.56, p  0.02). The extent of cor-
onary artery disease (single vessel vs. multivessel vs. left main) did not affect the relative increase in the risk of
stroke observed with CABG compared with PCI at either 30 days (p  0.57 for interaction) or midterm follow-up
(p  0.08 for interaction). Similar results were observed when the outcomes in 33,980 patients from 27 obser-
vational studies were analyzed.
Conclusions Coronary revascularization by CABG compared with PCI is associated with an increased risk of stroke at 30 days and
at the mid-term follow-up. (J Am Coll Cardiol 2012;60:798–805) © 2012 by the American College of Cardiology
Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2011.10.912a
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CWhether stroke is more frequent after coronary artery
bypass graft (CABG) surgery compared with percutaneous
coronary intervention (PCI) is controversial. Significant
differences in the risk of stroke between CABG and PCI
have not been found in most individual randomized con-
rolled trials (RCT) (1,2), the 1 exception being the SYNTAX
Synergy between PCI with Taxus and Cardiac Surgery)
rial, in which a significantly higher risk of stroke was
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2011, accepted October 17, 2011.pparent for patients treated with CABG (3). However, all
CT to date were powered insufficiently to detect differ-
nces in stroke between CABG and PCI, possibly resulting
n false positive or false negative findings. We therefore
erformed a meta-analysis to determine whether CABG is
ssociated with similar or higher rates of stroke than PCI
fter coronary revascularization across the spectrum of
oronary artery disease (CAD).
ethods
atients and end points. RCT comparing CABG versus
CI in patients with single-vessel CAD, multivessel CAD,
nd unprotected left main CAD in which the rate of stroke
t 30 days, midterm follow-up, or both were included. The
rimary end point was the 30-day rate of stroke with
ABG versus PCI. The secondary end point was the risk oftroke at the midterm follow-up.
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August 28, 2012:798–805 Stroke after CABG or PCIData source and study selection. Relevant trials were identi-
fied through MEDLINE, Cochrane, and EMBASE data-
base searches using the keywords coronary angioplasty, coro-
nary artery bypass, single-vessel coronary artery disease,
multivessel coronary artery disease, and left main coronary
artery disease. Two investigators (T.P., L.A.) independently
reviewed the titles, abstracts, and studies to determine whether
they met the inclusion criteria. Conflicts between reviewers
were resolved by consensus.
Statistical analysis. Data from RCT comprised the pri-
mary analysis set, whereas data from observational studies
were considered secondary. The odds ratio (OR) and 95%
confidence interval (CI) were used as the summary statistic.
The pooled OR was calculated by using both fixed-effect
(inverse variance-weighted) and random-effect (DerSimo-
nian and Laird) models. Median follow-up and number
needed to harm were calculated as previously described for
meta-analysis (4,5). Potential interactions between revascu-
larization method and the extent of CAD on the risk of
stroke also were analyzed. Sensitivity analysis, between-
study heterogeneity of effects, and publication bias were
assessed as previously described (6,7). Statistical analyses
were performed using Stata/SE software version 11.2
(StataCorp LP, College Station, Texas). Values of p  0.05
ere considered statistically significant.
esults
f 2,191 potentially relevant articles initially screened, 19
CT with 10,944 patients (including 5,448 assigned to
ABG and 5,496 assigned to PCI) met the inclusion criteria
nd were included in the final meta-analysis (Fig. 1, Online
Figure 1 Flow Diagram of the Study
Among the 2,191 potentially relevant articles, 19 were included in the final meta-a
CABG  coronary artery bypass graft surgery; PCI  percutaneous coronary interveTable 1). Patient characteristics
appear in Table 1. Stroke defini-
tions and the association between
stroke and subsequent mortality
are reported in Online Table 2.
Risk of stroke at 30-day follow-
up. Fourteen trials with 8,744
randomized patients contributed
to this analysis. As shown in
Figure 2A and Table 2, patients
treated with CABG had signifi-
cantly higher rates of stroke than
patients treated with PCI (1.20%
vs. 0.34%, OR: 2.94, 95% CI:
1.69 to 5.09, p 0.0001). The number needed to harm was
155, with an excess of 7 strokes for every 1,000 patients treated
with CABG rather than PCI. No significant interaction with
the period in which the studies were performed was apparent
(p  0.25 for interaction) (Online Fig. 1). A gradient in the
risk of stroke was observed in relation to the extent of CAD for
patients treated with CABG, but not with PCI, although the
interaction was not significant (p 0.57 for interaction) (Fig. 3A),
or was there a relationship between the OR of stroke at the
0-day follow-up with CABG versus PCI in trials in which
tents were used as opposed to balloon angioplasty only (p
0.52 for interaction).
Risk of stroke at midterm follow-up. Twelve studies includ-
ing a total of 7,052 patients contributed to this analysis. After
a median follow-up of 12.1 months, patients treated with
CABG had significantly higher rates of stroke than patients
treated with PCI (1.84% vs. 0.99%, OR: 1.67, 95% CI: 1.09
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
CAD  coronary artery
disease
CI  confidence interval
OR  odds ratio
PCI  percutaneous
coronary intervention
RCT  randomized
controlled trial
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Stroke after CABG or PCI August 28, 2012:798–805to 2.56, p  0.02) (Fig. 2B, Table 2). A gradient in the risk
f stroke was observed in relation to the extent of CAD only
or patients treated with CABG, with nonsignificant inter-
ction (p  0.08 for interaction) (Fig. 3B).
isk of stroke in observational studies. Similar findings
ere observed when we analyzed the results from 27 studies
ncluding 33,980 patients enrolled in observational studies
Online Table 3). As shown in Figure 4 and Table 2,
atients treated with CABG had an increased risk of stroke
ompared with PCI both at 30 days and at a median
ollow-up of 14.2 months.
No significant heterogeneity was apparent across studies,
nd there was no apparent systematic bias as assessed by
Clinical Characteristics of Patients Enrolled in the Trials Included iTable 1 Clinical Characteristics of Patients Enrolled in the Tria
Study Treatment
Age
(yrs)†
Male
(%)
Diabe
(%
ARTS I CABG (n 605) 61 9 76 16
PCI (n 600) 61 10 77 19
AWESOME CABG (n 232) 67 NA 34
PCI (n 222) 67 NA 29
BARI CABG (n 914) 61.1 74 25
PCI (n 915) 61.8 73 24
CARDIa CABG (n 254) 63.6 9.1 77.9 100
PCI (n 256) 64.3 8.5 70.7 100
EAST CABG (n 194) 61.4 10.0 72.7 21
PCI (n 198) 61.8 10.1 74.7 24
ERACI II CABG (n 225) 61.4 10.1 81.4 17
PCI (n 225) 62.5 11.5 77.3 17
GABI CABG (n 177) NA 80 15
PCI (n 182) NA 79 10
MASS II CABG (n 203) 60 9 72 29
PCI (n 205) 60 9 67 23
SoS CABG (n 500) 62 9.5 78 15
PCI (n 488) 61 9.2 80 14
SYNTAX CABG (n 897) 65.0 9.8 78.9 24
PCI (n 903) 65.2 9.7 76.4 35
SYNTAX Left Main CABG (n 348) 65.6 10.1 75.6 25
PCI (n 357) 65.4 9.8 72.0 23
Budriot CABG (n 101) 69 (63–73)‡ 77 33
PCI (n 100) 66 (62–73)‡ 72 40
Le Mans CABG (n 53) 61.3 8.4 73 17
PCI (n 52) 60.6 10.5 60 19
PRECOMBAT CABG (n 300) 62.7 9.5 77.0 30
PCI (n 300) 61.8 10.0 76.0 34
RITA CABG (n 501) 38% 60 yrs 79 NA
PCI (n 510) 35% 60 yrs 83 NA
Groningen CABG (n 51) 60 1.6 78 8
PCI (n 51) 61 1.3 75 18
Leipzig CABG (n 110) 61.6 10.0 77 25
PCI (n 110) 62.5 10.2 79 34
Seoul CABG (n 70) 61.4 9.9 64.3 48
PCI (n 119) 60.5 9.6 63.9 37
SIMA CABG (n 59) 60 83 13
PCI (n 62) 59 76 11
*Data are provided as they appear in the original publication. †Continuous data are provided as m
ACS  acute coronary syndrome; CABG  coronary artery bypass graft surgery; LVEF  left ven
ntervention.unnel plots and Peter’s test (Table 2). No individual study snduly influenced the primary effect estimate for either the
CT or observational studies.
iscussion
he main results of the current study, drawn from 19 RCT
n which 10,944 patients were enrolled, are as follows: (1)
atients with CAD undergoing CABG have a significantly
igher risk of stroke than those treated with PCI, both at 30
ays and after a median follow-up of 12.1 months; (2)
lthough stroke rates were higher in patients with more
xtensive CAD (especially after CABG), the relative in-
rease in stroke with CABG compared with PCI was not
Meta-Analysis*luded in the Meta-Analysis*
Hypertension
(%)
Hyperlipidemia
(%)
Prior MI
(%)
LVEF
(%)†
ACS
(%)
45 58 42 60 13 35
45 58 44 61 12 37
69 NA 71 44 NA
67 NA 70 47 NA
49 NA 55 57.6 65
49 NA 54 57.1 63
80.6 87.3 NA 60.0 12.7 NA
76.6 92.9 NA 59.1 14.4 NA
51.5 NA 40.7 62.0 11.8 NA
53.5 NA 40.9 60.8 11.6 NA
70.5 60.2 27.7 NA 90.7
71.0 62.5 28.5 NA 92.1
39 61 47 NA 15
42 60 46 NA 13
63 NA 41 67 9 0
61 NA 52 67 8 0
47 50 47 57 22
43 53 44 57 19
NA 77.2 33.8 NA 28.0
NA 78.7 31.9 NA 28.9
NA 75.4 25.4 NA 29.0
NA 81.0 28.5 NA 30.5
82 64 14 65 (55–68)‡ NA
82 68 19 65 (55–70)‡ NA
70 60 32 53.7 6.7 NA
75 65 36 53.5 10.7 NA
51.3 40.0 6.7 60.6 8.5 48.0
54.3 42.3 4.3 61.7 8.3 42.7
NA NA 42 NA 55
NA NA 43 NA 55
16 41 24 NA 45
33 45 18 NA 27
71 73 45 63 11 0
72 70 45 62 15 0
55.7 51.4 22.9 51.9 9.1 42.9
50.4 54.6 21.8 52.8 8.8 50.4
48 55 2 67 49
46 62 2 67 48
r mean  SD, unless otherwise specified. ‡Median (interquartile range).
r ejection fraction; MI  myocardial infarction; NA  not available; PCI  percutaneous coronaryn thels Inc
tes
)
.2
.7
.3
.3
.6
.6
.6
.8
.0
.0
.6
.0
ean oignificantly affected by the extent of disease; and (3) the risk
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August 28, 2012:798–805 Stroke after CABG or PCIFigure 2 Risk of Stroke With CABG Surgery Versus PCI in Randomized Trials
(A) 30-day and (B) midterm (median follow-up of 12.1 months) odds ratio (OR) and 95% confidence interval (CI) of stroke in patients (pts) treated with CABG versus
those treated with PCI. Results are reported in a logarithmic scale. ARTS  Arterial Revascularization Therapies Study; AWESOME  Angina With Extremely Serious Oper-
ative Mortality Evaluation; BARI  Bypass Angioplasty Revascularization Investigation; CARDIa  Coronary Artery Revascularisation in Diabetes; CI  confidence interval;
EAST  Emory Angioplasty versus Surgery Trial; ERACI  Argentine Randomized Study: Coronary Angioplasty with Stenting vs. Coronary Bypass Surgery in Multivessel
Disease; GABI  German Angioplasty Bypass Investigation; LE MANS  Study of Unprotected Left Main Stenting Versus Bypass Surgery; MASS  Medicine, Angioplasty,
or Surgery Study; OR  odds ratio; PRECOMBAT  Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients
with Left Main Coronary Artery Disease; RITA  Randomised Intervention Treatment of Angina; SIMA  Stenting vs. Internal Mammary Artery; SoS  Stent or Surgery;
SYNTAX  Synergy between PCI with Taxus and cardiac surgery; other abbreviations as in Figure 1.
; OR 
U
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Stroke after CABG or PCI August 28, 2012:798–805of stroke was substantially higher in observational studies
than in RCT for patients treated with CABG (but not with
PCI), and the relative reduction in stroke with PCI com-
pared with CABG was even more pronounced in these
so-called real-world studies, particularly at 30 days.
Debate over the optimal strategy of revascularization in
patients with CAD has continued over several decades
(1–3,6,7). Contrary to widespread belief, surprisingly few
data on the relative risk of stroke between PCI and CABG
are available (6), and a statistically significantly higher rate
of stroke with CABG has been reported only from a single
randomized study, the recent SYNTAX trial, in which
patients with triple vessel and left main CAD were enrolled
(3). Whether the findings of the SYNTAX trial are real and
representative or denote the play of chance is uncertain.
Our meta-analysis, which includes 10,944 patients from
19 RCT clearly demonstrates that patients treated with
CABG have a significantly higher risk of stroke than those
treated with PCI. This risk appears by 30 days, with an
excess of 7 strokes for every 1,000 patients treated with
CABG rather than PCI, and remains consistent after a
median follow-up of 12.1 months. Although stroke rates
were higher in patients with more extensive CAD, the
extent of atherosclerosis did not affect significantly the
relative increase in stroke risk with CABG compared with
PCI. The results from the observational studies confirm
those from the RCT. The large number of patients included
in this study and the satisfaction of all requirements for
meta-analysis, in terms of low heterogeneity, absent publi-
cation bias, and sensitivity analysis, provide robust scientific
validity to our findings, which can assist informed decision
making by patients, their families, and physicians when
deciding on the optimal strategy of revascularization in
patients with severe CAD.
Two prior meta-analyses have analyzed the risk of stroke
after CABG or PCI, with conflicting results (6,7). Com-
pared with those studies, the present analysis is significantly
Odds Ratio, Heterogeneity, and Publication Bias Across Randomizean Observational Studies Included in the Meta-Analy isTable 2 Odds Ratio, Heterog ne ty, and Public tion Bi s Acrosand Observational Studies Included in the Meta-Analys
Studies
(n)
Patients
(n)
Fixed Effects
OR (95% CI)*
RCTs, 30 days, all 14 8,744 2.94 (1.69–5.09)
RCTs, 30 days, MVCAD only† 8 6,192 2.62 (1.40–4.91)
RCTs, 30 days, ULMCAD only 3 1,011 6.29 (1.11–35.77)
RCTs, 30 days, SVCAD only 3 530 1.76 (0.27–11.24)
RCTs, 1 yr, all 12 7,052 1.67 (1.09–2.56)
RCTs, 1 yr, SVCAD only 4 632 0.69 (0.16–3.00)
RCTs, 1 yr, MVCAD only 4 3,798 1.79 (1.02–3.12)
RCTs, 1 yr, ULMCAD only 4 1,611 6.58 (1.72–25.16)
Observational studies, 30 days 27 33,980 6.38 (4.68–8.70)
Observational studies, 1 yr 13 18,250 2.08 (1.63–2.66)
*OR of coronary artery bypass grafting surgery versus percutaneous coronary intervention. †The R
with MVCAD and SVCAD.
CI  confidence interval; HET  heterogeneity; MVCAD  multivessel coronary artery disease
LMCAD  unprotected left main coronary artery disease; other abbreviation as in Table 1.larger, analyzed the relative rates of stroke both at 30 daysand at the 1-year follow-up, and included patients with
unprotected left main CAD. Also unique is our examination
of the data for possible interactions between revasculariza-
tion method and the extent of CAD and the inclusion of a
separate meta-analysis of observational studies, which pro-
vides supportive insight into real-world outcomes with
CABG versus PCI.
Some studies have reported that off-pump compared with
on-pump CABG may reduce the risk of stroke significantly
(8), but these findings have not been confirmed in other
studies (9). In RCT included in our meta-analysis, off-
pump surgery was almost exclusively used in patients with
single-vessel CAD. For this reason, we could not determine
whether there was an interaction between surgical technique
and the risk of stroke with CABG. Careful pre-operative
evaluation of patient risk factors, screening of the ascending
aorta, assessment of carotid artery disease, implementation
of no-touch techniques in high-risk patients, and aggressive
and prompt treatment of post-operative atrial fibrillation
remain mainstay strategies to reduce the risk of stroke in
CABG-treated patients.
Study limitations. This report has some limitations that
should be acknowledged. Follow-up was restricted to 1 year,
and therefore whether the observed differences would re-
main constant, increase, or diminish with longer-term follow-up
is unknown. Because this meta-analysis was based on
aggregate data, we could not analyze the potential influence
of classical risk factors for stroke such as diabetes and prior
stroke. Few studies reported mortality rates subsequent to
stroke occurrence, and therefore we could not investigate
the relation between stroke and mortality. Definitions of
stroke were not uniform across trials. Finally, observational
studies are subject to confounding, and these results were
not adjusted for differences in baseline characteristics.
Nonetheless, the results in these real-world patients were
consistent with those from the RCT, providing support that
the observed differences in stroke between CABG and PCI
ntrolled Trialsdomized Controlled Trials
lue
Random Effects
OR (95% CI)* p Value I2 (%)
Heterogeneity
p Value
Peter’s
Test
001 2.94 (1.69–5.09) 0.0001 0.0% 0.97 0.43
03 2.62 (1.40–4.91) 0.003 0.0% 0.96 0.86
4 6.29 (1.11–35.77) 0.04 0.0% 0.95 NA
5 1.76 (0.27–11.24) 0.55 0.0% 0.47 NA
2 1.69 (1.07–2.66) 0.02 4.8% 0.40 0.69
2 0.69 (0.16–3.00) 0.62 0.0% 0.58 NA
4 1.79 (1.02–3.12) 0.04 0.0% 0.46 0.09
06 6.58 (1.72–25.16) 0.006 0.0% 0.98 NA
001 6.38 (4.68–8.70) 0.0001 0.0% 0.97 0.61
001 2.12 (1.60–2.81) 0.0001 7.5% 0.37 0.40
l was not included in the stratification analysis because it enrolled a similar proportion of patients
odds ratio; RCT  randomized controlled trial; SVCAD  single vessel coronary artery disease;d Cos Ra
is
p Va
0.0
0.0
0.0
0.5
0.0
0.6
0.0
0.0
0.0
0.0
ITA triaare real.
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August 28, 2012:798–805 Stroke after CABG or PCIFigure 3 Risk of Stroke With CABG Versus PCI in Patients Stratified by the Extent of Coronary Disease
(A) 30-day and (B) midterm (median follow-up of 12.1 months) OR and 95% CI of stroke in pts treated with CABG versus those treated with PCI, stratified by multivessel
coronary artery disease (MVCAD), unprotected left main coronary artery disease (ULMCAD), or single-vessel coronary artery disease (SVCAD). Results are reported in a
logarithmic scale. Abbreviations as in Figures 1 and 2.
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Stroke after CABG or PCI August 28, 2012:798–805Figure 4 Risk of Stroke With CABG Versus PCI in Observational Studies
(A) 30-day and (B) midterm (median follow-up of 14.2 months) OR and 95% CI of stroke in patients treated with CABG versus those treated with PCI.
Results are reported in a logarithmic scale. Abbreviations as in Figures 1 and 2.
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August 28, 2012:798–805 Stroke after CABG or PCIConclusions
In this large contemporary meta-analysis of patients with
CAD undergoing revascularization, CABG was associated
with significantly higher rates of stroke compared with PCI
at 30 days and 1 year, with no significant interaction
apparent between the extent of CAD and revascularization
method on the relative risk of stroke.
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